AU Patent

AU2020217386A1 — Pharmaceutical composition, comprising phosphate binder particles

Assigned to Vifor International AG · Expires 2020-09-03 · 6y expired

What this patent protects

: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide 5 having a certain…

USPTO Abstract

: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide 5 having a certain particle size distribution for the manufacture of a pharmaceutical composition.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020217386A1
Jurisdiction
AU
Classification
—
Expires
2020-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Vifor International AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.